电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD47 (Magrolimab Biosimilar) 抗体

The Human 单克隆 anti-CD47 (Magrolimab Biosimilar) antibody is suitable to detect CD47 (Magrolimab Biosimilar) in samples from 人. It has been validated for ELISA, FACS, BLI, Func 和 SPR.
产品编号 ABIN7675722
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant CD47 (Magrolimab Biosimilar) 抗体 (ABIN7675722)

抗原

CD47 (Magrolimab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 10
  • 2
  • 1
  • 1
Human

克隆类型

  • 11
  • 3
单克隆

标记

  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD47 (Magrolimab Biosimilar) antibody is un-conjugated

应用范围

ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-CD47 Reference Antibody (magrolimab)

    序列

    QVQLVQSGAE VKKPGASVKV SCKASGYTFT NYNMHWVRQA PGQRLEWMGT IYPGNDDTSY NQKFKDRVTI TADTSASTAY MELSSLRSED TAVYYCARGG YRAMDYWGQG TLVTVSSAST KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE FLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP SQEEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD KSRWQEGNVF SCSVMHEALH NHYTQKSLSL SLGK,DIVMTQSPLS LPVTPGEPAS ISCRSSQSIV YSNGNTYLGW YLQKPGQSPQ LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCFQGSHVP YTFGQGTKLE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC

    产品特性

    Anti-CD47 Reference Antibody (magrolimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG4 S228P
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: CD47 inhibitors

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    CD47 (Magrolimab Biosimilar)

    物质类

    Biosimilar

    分子量

    145.5 kDa

    UniProt

    Q08722
You are here: